Sime Darby Oils, Dr. B.R. Shetty's ADVOC announce strategic partnership for MENA region
Via the partnership, SDO and ADVOC will operate in the region as a single sales and marketing team
Press Release - 19-Aug-2019
Neopharma LLC
Last updated on: 04 October 2019
fast facts
Business SummaryManufacture of generic drugs; provides marketing and research services.Country of IncorporationUAEOwnership TypeForeignEstablished In2003Primary SectorHealth CareNumber of Employees445Latest News
business
GSK and Neopharma partner to accelerate supply of medicines to patients in the UAE
GSK partners with Neopharma to localize its Secondary Packaging stage - the last phase of the manufacturing process before distribution and sale.
Press Release - 29-Apr-2019Neopharma continues with its Global journey; acquires a manufacturing facility in US from Dr. Reddy's Laboratories
The Bristol site has had a long history first with the British drug maker GlaxoSmithKline (GSK) and then with Dr. Reddy's in manufacturing the brands Augmentin® and Amoxil®.
Press Release - 07-Oct-2018Neopharma acquires a manufacturing facility in US
Neopharma has five globally accredited pharmaceutical manufacturing facilities in three continents
Khaleej Times - 06-Oct-2018Neopharma acquires US antibiotic manufacturing facility
Takeover conducted on Monday for an undisclosed sum
Mubasher - 02-Oct-2018Contact details
Primary address
Building 89-95Mussafah Street
Industrial City of Abu Dhabi (ICAD), Plot A-1
72900
UAE
Abu Dhabi
Region
Abu DhabiCONTACT
- Tel: +971 2-550-1000
- Fax: +971 2-550-1199
- Email: neopharma@neopharma.ae
- www.neopharmauae.com
Find Out More Information
Have questions regarding this company profile? Get detailed company information on Thomson Reuters Business Development MENA.
Company information provided by © 2019 Thomson Reuters
Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).